PMID- 16455781 OWN - NLM STAT- MEDLINE DCOM- 20060523 LR - 20221207 IS - 0013-7227 (Print) IS - 0013-7227 (Linking) VI - 147 IP - 5 DP - 2006 May TI - Regulation of hepatic insulin-like growth factor-binding protein-1 gene expression by insulin: central role for mammalian target of rapamycin independent of forkhead box O proteins. PG - 2383-91 AB - The expression of IGF-binding protein-1 (IGFBP-1) is induced in rat liver by dexamethasone and glucagon and is completely inhibited by 100 nM insulin. Various studies have implicated phosphatidylinositol 3-kinase, protein kinase B (Akt), phosphorylation of the transcription factors forkhead in rhabdomyosarcoma 1 (Foxo1)/Foxo3, and the mammalian target of rapamycin (mTOR) in insulin's effect. In this study we examined insulin regulation of IGFBP-1 in both subconfluent and confluent hepatocytes. In subconfluent hepatocytes, insulin inhibition of IGFBP-1 mRNA levels was blocked by inhibiting PI3 kinase activation, and there was a corresponding inhibition of Foxo1/Foxo3 phosphorylation. In these same cells, inhibition of the insulin effect by rapamycin occurred in the presence of insulin-induced Foxo1/Foxo3 phosphorylation. In confluent hepatocytes, insulin could not activate the phosphatidylinositol 3-kinase (PI3 kinase)-Akt-Foxo1/Foxo3 pathway, but still inhibited IGFBP-1 gene expression in an mTOR-dependent manner. In subconfluent hepatocytes, the serine/threonine phosphatase inhibitor okadaic acid (100 nM) partially inhibited IGFBP-1 gene expression by 40%, but did not produce phosphorylation of either Akt or Foxo proteins. In contrast, 1 nm insulin inhibited the IGFBP-1 mRNA level by 40% and correspondingly activated Akt and Foxo1/Foxo3 phosphorylation to a level comparable to that observed with 100 nM insulin. These results suggest a potential role for a serine/threonine phosphatase(s) in the regulation of IGFBP-1 gene transcription, which is not downstream of mTOR and is independent of Akt. In conclusion, we have found that in rat liver, insulin inhibition of IGFBP-1 mRNA levels can occur in the absence of the phosphorylation of Foxo1/Foxo3, whereas activation of the mTOR pathway is both necessary and sufficient. FAU - Mounier, Catherine AU - Mounier C AD - Polypeptide Hormone Laboratory, Faculty of Medicine, McGill University, Montreal, Quebec, Canada. FAU - Dumas, Victor AU - Dumas V FAU - Posner, Barry I AU - Posner BI LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060202 PL - United States TA - Endocrinology JT - Endocrinology JID - 0375040 RN - 0 (Androstadienes) RN - 0 (FOXO3 protein, rat) RN - 0 (Forkhead Box Protein O3) RN - 0 (Forkhead Transcription Factors) RN - 0 (Insulin) RN - 0 (Insulin-Like Growth Factor Binding Protein 1) RN - 0 (Nerve Tissue Proteins) RN - 0 (RNA, Messenger) RN - 0 (Foxo1 protein, rat) RN - 1W21G5Q4N2 (Okadaic Acid) RN - 63231-63-0 (RNA) RN - 7S5I7G3JQL (Dexamethasone) RN - 9007-92-5 (Glucagon) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.1.1 (mTOR protein, rat) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - XVA4O219QW (Wortmannin) SB - IM MH - Androstadienes/pharmacology MH - Animals MH - Blotting, Western MH - Cells, Cultured MH - Dexamethasone/pharmacology MH - Dose-Response Relationship, Drug MH - Forkhead Box Protein O3 MH - Forkhead Transcription Factors/metabolism MH - *Gene Expression Regulation MH - Genes, Dominant MH - Glucagon/metabolism MH - Hepatocytes/metabolism MH - Insulin/*metabolism MH - Insulin-Like Growth Factor Binding Protein 1/*biosynthesis/*genetics/metabolism MH - Liver/*metabolism MH - Male MH - Nerve Tissue Proteins/metabolism MH - Okadaic Acid/metabolism MH - Phosphatidylinositol 3-Kinases/metabolism MH - Phosphorylation MH - Protein Kinases/*metabolism MH - Proto-Oncogene Proteins c-akt/metabolism MH - RNA/metabolism MH - RNA, Messenger/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Signal Transduction MH - Swine MH - TOR Serine-Threonine Kinases MH - Time Factors MH - Wortmannin EDAT- 2006/02/04 09:00 MHDA- 2006/05/24 09:00 CRDT- 2006/02/04 09:00 PHST- 2006/02/04 09:00 [pubmed] PHST- 2006/05/24 09:00 [medline] PHST- 2006/02/04 09:00 [entrez] AID - en.2005-0902 [pii] AID - 10.1210/en.2005-0902 [doi] PST - ppublish SO - Endocrinology. 2006 May;147(5):2383-91. doi: 10.1210/en.2005-0902. Epub 2006 Feb 2.